Skip to main content

. 1985 Oct 19;291(6502):1092–1093. doi: 10.1136/bmj.291.6502.1092-a

Control of an outbreak of systemic Candida albicans.

J P Burnie, W Lee, J D Williams, R C Matthews, F C Odds

PMCID: PMC1416996 PMID: 3931809

1092

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burnie J. P., Odds F. C., Lee W., Webster C., Williams J. D. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med J (Clin Res Ed) 1985 Mar 9;290(6470):746–748. doi: 10.1136/bmj.290.6470.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
Donnelly J. P., Starke I. D., Galton D. A., Catovsky D., Goldman J. M., Darrell J. H. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. J Hosp Infect. 1984 Mar;5(1):83–91. doi: 10.1016/0195-6701(84)90105-1. [DOI] [PubMed] [Google Scholar]
Drouhet E., Dupont B. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Am J Med. 1983 Jan 24;74(1B):30–47. doi: 10.1016/0002-9343(83)90512-0. [DOI] [PubMed] [Google Scholar]
Hann I. M., Prentice H. G., Corringham R., Blacklock H. A., Keaney M., Shannon M., Noone P., Gascoigne E., Fox J., Boesen E. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet. 1982 Apr 10;1(8276):826–829. doi: 10.1016/s0140-6736(82)91874-8. [DOI] [PubMed] [Google Scholar]
Hay R. J. Ketoconazole: a reappraisal. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):260–261. doi: 10.1136/bmj.290.6464.260. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES